Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s ...

Enforcement action will be taken against any company marketing the products for children under the age of 3 or who are at low or moderate risk for tooth decay.

A popular muscle relaxer made in New Jersey is being recalled due to a label swap, according to the FDA. The product was ...

U.S. President Donald Trump's embrace of an old generic drug called leucovorin for use against a rare disorder that causes ...

This is not just about one device. It’s about what happens when institutions grow comfortable living in their own ambiguity and hiding behind opacity.” ...

More than half a million bottles of blood pressure medication are being recalled over a cancer-causing chemical connected to ...

The FDA denied approving DCA to treat a rare disorder called PDCD. The Higbees are urging the agency to reconsider.

Secretary of Health and Human Services Robert F. Kennedy, Jr., recently announced that the U.S. Food and Drug Administration will launch a review of the safety of the abortion pill, mifepristone.

The FDA approved a label update for Winrevair to include that it lowers the risk for clinical worsening events in adults with ...

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 ...

Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...

British American Tobacco said it has paused a pilot plan to launch an unlicensed disposable vape in the U.S., as the Food and ...